Oramed Pharmaceuticals, Inc Live Stock Price Today, Share Analysis and Chart

Name: Oramed Pharmaceuticals, Inc: Is Infosys Ltd. worth buying?
Item: Oramed Pharmaceuticals, Inc
Rating: 1.58158325
Author: Trendlyne DVM scores

about

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form int...

2.20 -0.01 (-0.45%)

28.80% Fall from 52W High

79,254

XNAS Volume

XNAS 28 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

17.8 / 100

Technically Neutral

45.4 / 100

1Yr Price target upside is 48%

1 analysts

Oramed Pharmaceuticals, Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Oramed Pharmaceuticals, Inc Live Stock Price Today, Share Analysis and Chart

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form int...

28.80% Fall from 52W High

SWOT Analysis

Oramed Pharmaceuticals, Inc Live Price Chart